Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terragene is an Argentina-based infection prevention and sterilization assurance company focused on healthcare, dental, pharmaceutical, medical device, and laboratory markets. Founded in 2006, it develops and manufactures biological indicators, chemical indicators, auto-reader incubators, traceability software, cleaning verification products, and other workflow tools used to monitor sterilization, washing, and disinfection processes. The company positions itself as a biotechnology-based manufacturer with in-house research, development, and production capabilities, and distributes products internationally across more than 70 countries. Its portfolio includes rapid-read sterilization monitoring systems such as Photon and Hyper, protein detection products such as Pro1, and digital solutions for CSSD/SPD traceability. Terragene also offers OEM and private-label development services for partners seeking branded infection prevention products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Terragene.